LCD L38629: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian
Policy LCD-L38629 · Multi-specialty
New LCD impacts molecular testing billing practices.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code Z94.1.
Signal breakdown
8 shown · 8 total in platform
Critical
0%
High
88%
Routine
0%
Low
12%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L38629 · Multi-specialty
New LCD impacts molecular testing billing practices.
Policy LCD-L38671 · Transplantation
New LCD for organ rejection testing impacts billing compliance.
Policy LCD-L38568 · Multi-specialty
New LCD for molecular testing impacts billing practices.
Policy LCD-DL40140 · Clinical Laboratory
Impact of new LCD on organ transplant testing reimbursement.
Policy LCD-DL40058 · Clinical Laboratory
New LCD may change billing for organ transplant tests.
Policy LCD-DL40062 · Multi-specialty
Impact of LCD on organ transplant testing reimbursements.
Policy LCD-DL40060 · Nephrology
New LCD could reshape billing for organ transplant tests.
Policy LCD-L33824 · DME
DME MAC LCD for immunosuppressive drugs effective Jan 1, 2026.
Audit documentation
The Tripwire Audit Pack exports 12 months of Multi-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.